SPERO THERAPEUTICS
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Its lead program addresses a novel target driving virulence and persistence of pseudomonas aeruginosa infections and other gram-negative pathogens.
SPERO THERAPEUTICS
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.sperotherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1 857 242 1600
Total Funding:
434.56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
BioAegis Therapeutics
BioAegis is developing therapeutics for infectious, inflammatory and degenerative diseases based on the platform of plasma gelsolin.
Feldan Therapeutics
Feldan Therapeutics has developed a patented peptide-based technology platform.
Galera Therapeutics
Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.
Inspire Medical Systems
Inspire Medical Systems develops implantable therapeutic devices for the treatment of obstructive sleep apnea.
Marker Therapeutics
Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.
MediSieve
MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Mitobridge
Mitobridge is discovering and developing small molecule therapeutics that improve mitochondrial functions.
Naked Biome
Naked Biome is a microbiome-based therapeutics company, launching advanced therapies to treat and prevent skin disease.
Nine Square Therapeutics
Nine Square Therapeutics is a developer of novel therapies for movement disorders.
NovaDigm Therapeutics
NovaDigm Therapeutics develops vaccines that protect patients from contracting fungal and bacterial infections.
Prota Therapeutics
Prota Therapeutics is a developer of new treatment for peanut allergy in children.
Siolta Therapeutics
Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.
Strand Therapeutics
Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.
Swing Therapeutics
Swing Therapeutics provides digital therapeutics for people with chronic conditions.
Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Spero Therapeutics
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Post-IPO Debt - Spero Therapeutics
Pfizer
Pfizer investment in Post-IPO Equity - Spero Therapeutics
National Science Foundation
National Science Foundation investment in Grant - Spero Therapeutics
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Spero Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Post-IPO Equity - Spero Therapeutics
CARB-X
CARB-X investment in Grant - Spero Therapeutics
GV
GV investment in Series C - Spero Therapeutics
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series C - Spero Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series C - Spero Therapeutics
Official Site Inspections
http://www.sperotherapeutics.com Semrush global rank: 4.14 M Semrush visits lastest month: 2.9 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
